Windtree Therapeutics Stock Buy Hold or Sell Recommendation
| WINT Stock | USD 4.10 0.24 5.53% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Windtree Therapeutics is 'Strong Sell'. Macroaxis provides Windtree Therapeutics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding WINT positions. The advice algorithm takes into account all of Windtree Therapeutics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Windtree Therapeutics' buy or sell advice are summarized below:
Real Value 4.47 | Target Price 5 | Hype Value 5.92 | Market Value 4.1 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Windtree Therapeutics given historical horizon and risk tolerance towards Windtree Therapeutics. When Macroaxis issues a 'buy' or 'sell' recommendation for Windtree Therapeutics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Windtree |
Execute Windtree Therapeutics Buy or Sell Advice
The Windtree recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Windtree Therapeutics. Macroaxis does not own or have any residual interests in Windtree Therapeutics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Windtree Therapeutics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Risky | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Hold | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Windtree Therapeutics Trading Alerts and Improvement Suggestions
| Windtree Therapeutics generated a negative expected return over the last 90 days | |
| Windtree Therapeutics has high historical volatility and very poor performance | |
| Windtree Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (20.29 M) with loss before overhead, payroll, taxes, and interest of (17.79 M). | |
| Windtree Therapeutics currently holds about 11.38 M in cash with (13.44 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37. | |
| Windtree Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from finance.yahoo.com: Insurance industry experts to focus on technology and risk at the CFMA annual conference |
Windtree Therapeutics Returns Distribution Density
The distribution of Windtree Therapeutics' historical returns is an attempt to chart the uncertainty of Windtree Therapeutics' future price movements. The chart of the probability distribution of Windtree Therapeutics daily returns describes the distribution of returns around its average expected value. We use Windtree Therapeutics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Windtree Therapeutics returns is essential to provide solid investment advice for Windtree Therapeutics.
| Mean Return | -0.53 | Value At Risk | -9.84 | Potential Upside | 9.15 | Standard Deviation | 5.66 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Windtree Therapeutics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Windtree Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Windtree Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Windtree Therapeutics backward and forwards among themselves. Windtree Therapeutics' institutional investor refers to the entity that pools money to purchase Windtree Therapeutics' securities or originates loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Citadel Advisors Llc | 2023-09-30 | 0.0 | Two Sigma Securities, Llc | 2023-09-30 | 0.0 | Alyeska Investment Group, L.p. | 2023-09-30 | 136.5 K | Vanguard Group Inc | 2023-12-31 | 41.6 K | Virtu Financial Llc | 2023-12-31 | 38.9 K | Geode Capital Management, Llc | 2023-12-31 | 14.2 K | Ubs Group Ag | 2023-12-31 | 510 | Wells Fargo & Co | 2023-12-31 | 32.0 | U.s. Bancorp | 2023-12-31 | 3.0 | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 2.0 | Advisor Group Holdings, Inc. | 2023-12-31 | 1.0 |
Windtree Therapeutics Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 11.4M | (5.6M) | 5.4M | (16.2M) | (1.9M) | (1.8M) | |
| Free Cash Flow | (24.9M) | (25.6M) | (23.9M) | (19.5M) | (13.5M) | (14.1M) | |
| Depreciation | 159K | 195K | 165K | 533K | 82K | 77.9K | |
| Capital Expenditures | 191K | 291K | 279K | 13K | 15K | 14.3K | |
| Net Income | (27.5M) | (32.6M) | (67.6M) | (39.2M) | (20.3M) | (21.3M) | |
| End Period Cash Flow | 22.7M | 17.1M | 22.5M | 6.3M | 4.3M | 4.1M | |
| Other Non Cash Items | 882K | 1.6M | 46.6M | 19.3M | 4.4M | 3.5M | |
| Net Borrowings | 6M | (1.1M) | (3.2M) | (3.9M) | (3.5M) | (3.3M) | |
| Change To Netincome | 4.3M | 8.4M | 8.4M | 43.8M | 50.4M | 52.9M | |
| Investments | 14.0M | (291K) | (279K) | 197K | (15K) | (15.8K) |
Windtree Therapeutics Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Windtree Therapeutics or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Windtree Therapeutics' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Windtree stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.55 | |
β | Beta against NYSE Composite | 0.13 | |
σ | Overall volatility | 5.71 | |
Ir | Information ratio | -0.11 |
Windtree Therapeutics Volatility Alert
Windtree Therapeutics exhibits very low volatility with skewness of 0.13 and kurtosis of 0.9. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Windtree Therapeutics' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Windtree Therapeutics' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Windtree Therapeutics Fundamentals Vs Peers
Comparing Windtree Therapeutics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Windtree Therapeutics' direct or indirect competition across all of the common fundamentals between Windtree Therapeutics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Windtree Therapeutics or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Windtree Therapeutics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Windtree Therapeutics by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Windtree Therapeutics to competition |
| Fundamentals | Windtree Therapeutics | Peer Average |
| Return On Equity | -3.03 | -0.31 |
| Return On Asset | -0.3 | -0.14 |
| Current Valuation | 14.6 M | 16.62 B |
| Shares Outstanding | 510.18 K | 571.82 M |
| Shares Owned By Insiders | 4.65 % | 10.09 % |
| Shares Owned By Institutions | 12.90 % | 39.21 % |
| Number Of Shares Shorted | 12.66 K | 4.71 M |
| Price To Earning | (0.05) X | 28.72 X |
| Price To Book | 0.53 X | 9.51 X |
| Price To Sales | 660.53 X | 11.42 X |
| Gross Profit | (17.79 M) | 27.38 B |
| EBITDA | (17.46 M) | 3.9 B |
| Net Income | (20.29 M) | 570.98 M |
| Cash And Equivalents | 11.38 M | 2.7 B |
| Cash Per Share | 0.37 X | 5.01 X |
| Total Debt | 16.83 M | 5.32 B |
| Debt To Equity | 0.95 % | 48.70 % |
| Current Ratio | 2.47 X | 2.16 X |
| Book Value Per Share | 10.18 X | 1.93 K |
| Cash Flow From Operations | (13.44 M) | 971.22 M |
| Short Ratio | 0.39 X | 4.00 X |
| Earnings Per Share | (94.32) X | 3.12 X |
| Target Price | 3.0 | |
| Beta | 0.61 | -0.15 |
| Market Capitalization | 2.09 M | 19.03 B |
| Total Asset | 32.41 M | 29.47 B |
| Retained Earnings | (844.82 M) | 9.33 B |
| Working Capital | 1.38 M | 1.48 B |
| Current Asset | 40.79 M | 9.34 B |
| Current Liabilities | 11.07 M | 7.9 B |
| Net Asset | 32.41 M |
Note: Payment of 8007 shares by John Tattory of Windtree Therapeutics subject to Rule 16b-3 [view details]
Windtree Therapeutics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Windtree . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Windtree Therapeutics Buy or Sell Advice
When is the right time to buy or sell Windtree Therapeutics? Buying financial instruments such as Windtree Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.| 2021 | 2022 | 2023 | 2024 (projected) | Short and Long Term Debt Total | 2.9M | 2.3M | 16.8M | 8.6M | Total Assets | 74.8M | 38.0M | 32.4M | 42.3M |
Use Investing Ideas to Build Portfolios
In addition to having Windtree Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy Funds Thematic Idea Now
Energy Funds
Funds or Etfs investing in energy sector, natural resources, and ecology. The Energy Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Windtree Therapeutics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Complementary Tools for Windtree Stock analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |
Is Windtree Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Windtree Therapeutics. If investors know Windtree will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.32) | Quarterly Revenue Growth (1.00) | Return On Assets (0.30) | Return On Equity (3.03) |
The market value of Windtree Therapeutics is measured differently than its book value, which is the value of Windtree that is recorded on the company's balance sheet. Investors also form their own opinion of Windtree Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Windtree Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Windtree Therapeutics' market value can be influenced by many factors that don't directly affect Windtree Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Windtree Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.